Most companies screen inconsistently because they have no formal policy. Here's how to build one from scratch — covering who to screen, when, and what to do with the results.
An undisclosed conflict of interest can compromise procurement decisions, board integrity, and regulatory compliance. Here's how to surface them before they become a liability.
Source of wealth screening is a regulatory requirement in many high-value transactions — but most businesses don't know what it involves or when it applies to them.
A person can have multiple names, multiple entities, and multiple risk connections. Social graph mapping connects the dots that a standard name search misses entirely.
Vendor onboarding is where most compliance failures begin. Here's a structured process for what to check, when to check it, and what triggers a deeper review.
Standard due diligence isn't always enough. Enhanced Due Diligence applies in high-risk situations — here's how to know when you need it and what it involves.
Healthcare vendors have access to the most sensitive data imaginable. Screening them once at onboarding is not enough — here's what a proper third-party risk process looks like in healthcare.
When a regulator or auditor asks you to justify a decision, your report is your defence. Here's what a professional-grade due diligence report must include.
Not all markets carry equal risk. Jurisdictional risk can invalidate an otherwise clean due diligence report. Here's how to factor it into every cross-border decision.
A PEP isn't necessarily corrupt — but transacting with one without screening creates serious regulatory exposure. Here's what you need to know.